related documents
- Analysis of the bleeding and thromboembolic risk with concomitant use of antiplatelet treatment in the AMPLIFY trial Conferences
- Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study Conferences
- Apixaban for the treatment of venous thromboembolism in cancer patients: data from the AMPLIFY trial Conferences
- Aripazine reverses unfractionated and low molecular weight heparins, fondaparinux and new Xa and IIa oral anticoagulants: report of Phase I/II clinical trial with edoxaban Conferences
- Association between naps, snore, sleep duration and obesity in the population of INTER-HEART China Study Conferences
- Combined CT angiographic assessment of area stenosis, lesion length and approach score is superior in prediction of functionally significant coronary stenosis than individual indices alone Conferences
- Cost effectiveness of device surgery without interruption of oral anticoagulation: results from the bridge or continue warfarin for device surgery randomized controlled trial (Bruise control) Conferences
- Dabigatran versus warfarin in patients with pacemaker or defibrillator wires in the RE-LY trial: the role of contact activation Conferences
- Immunosuppressive therapy limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) Conferences
- International normalized ratio control and 1-year outcomes in patients with newly diagnosed atrial fibrillation: the GARFIELD Registry Conferences
- Machine learning to predict myocardial injury and death after non-cardiac surgery Conferences
- Myocardial injury in hip fractures: a HIP ATTACK-1 randomized trial substudy Conferences
- Non invasive anatomical and functional assessment of coronary artery disease Conferences
- Outcome after MI in different socio-economic environments Conferences
- Risk of ischemic stroke or systemic embolism in aspirin-treated patients according to clinical presentation of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE or AVERROES Conferences
- Statin use reduces incidence of adverse events in patients with atrial fibrillation in the ACTIVE-W, ACTIVE-A and AVERROES studies Conferences
- Sustained reversal of apixaban anticoagulation with andexanet alfa using a bolus plus infusion regimen in a phase 2 placebo controlled trial Conferences
- The use of dabigatran according to body mass index: the RE-LY experience Conferences
- Treatment of acute pulmonary embolism with dabigatran or warfarin: a pooled analysis of efficacy data from RE-COVER and RE-COVER II Conferences
- Truly low-risk patients with newly diagnosed non-valvular atrial fibrillation at risk of stroke: 1-year outcomes from the GARFIELD Registry Conferences
- Which formula for estimating glomerular filtration rate is the better predictor of outcomes in heart failure with preserved ejection fraction? An analysis from the I-Preserve trial Conferences